Middle East & Africa Targeted Protein Degradation Market Size & Outlook

The targeted protein degradation market in Middle East & Africa is expected to reach a projected revenue of US$ 43.1 million by 2033. A compound annual growth rate of 21.3% is expected of Middle East & Africa targeted protein degradation market from 2026 to 2033.
Revenue, 2025 (US$M)
$8.9
Forecast, 2033 (US$M)
$43.1
CAGR, 2026 - 2033
21.3%
Report Coverage
Middle East & Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Middle East & Africa targeted protein degradation market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

MEA targeted protein degradation market highlights

  • The MEA targeted protein degradation market generated a revenue of USD 8.9 million in 2025.
  • The market is expected to grow at a CAGR of 21.3% from 2026 to 2033.
  • In terms of segment, protac was the largest revenue generating type in 2025.
  • Molecular Glues is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, UAE is expected to register the highest CAGR from 2026 to 2033.

MEA data book summary

Market revenue in 2025USD 8.9 million
Market revenue in 2033USD 43.1 million
Growth rate21.3% (CAGR from 2026 to 2033)
Largest segmentProtac
Fastest growing segmentMolecular Glues
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPROTAC, Molecular Glues, LYTACs, Others Type
Key market players worldwideThermo Fisher Scientific Inc, Bio-Techne Corp, Promega, Merck KGaA, BPS Bioscience Inc., Bayer AG, BroadPharm, BOC Sciences

Other key industry trends

  • In terms of revenue, MEA region accounted for 1.3% of the global targeted protein degradation market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 713.7 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Targeted Protein Degradation Market Companies

Name Profile # Employees HQ Website
BPS Bioscience Inc. View profile 51-100 San Diego, California, United States, North America http://bpsbioscience.com
BroadPharm View profile 11-50 San Diego, California, United States, North America https://broadpharm.com
Promega View profile 5001-10000 Madison, Wisconsin, United States, North America http://www.promega.com/es
Bio-Techne Corp View profile 3050 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 https://www.bio-techne.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

MEA targeted protein degradation market size, by country, 2021-2033 (US$M)

Middle East & Africa Targeted Protein Degradation Market Outlook Share, 2025 & 2033 (US$M)

MEA targeted protein degradation market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online